C-reactive protein as an outcome predictor for maintenance hemodialysis patients.
about
Responses of the skin microcirculation to acetylcholine and to sodium nitroprusside in chronic uremic patients.Prevalence of atrial fibrillation and its predictors in nondialysis patients with chronic kidney diseasePlasma proteomic analysis of the critical limb ischemia markers in diabetic patients with hemodialysis.Clinical utility of C-reactive protein measurements.Impact of inflammation on anemia of hemodialysis patients who were under treatment of recombinant human erythropoietin.Association of hsCRP, white blood cell count and ferritin with renal outcome in chronic kidney disease patients.Cross-over study of influence of oral vitamin C supplementation on inflammatory status in maintenance hemodialysis patients.Metabolism and clinical interest of serum transthyretin (prealbumin) in dialysis patients.Metabolic status and personality affect the prognosis of patients with continuous ambulatory peritoneal dialysis.C-reactive protein and prediction of 1-year mortality in prevalent hemodialysis patients.The effects of peritoneal dialysis and hemodialysis on serum tumor necrosis factor-alpha, interleukin-6, interleukin-10 and C-reactive-protein levelsThe effects of hemodialysis and peritoneal dialysis on serum homocysteine and C-reactive protein levelsCirculating bacterial-derived DNA fragment level is a strong predictor of cardiovascular disease in peritoneal dialysis patientsIL-6 levels, nutritional status, and mortality in prevalent hemodialysis patients.Associations of interleukin-6, C-reactive protein and serum amyloid A with mortality in haemodialysis patientsElevation of Interleukin-18 Correlates With Cardiovascular, Cerebrovascular, and Peripheral Vascular Events: A Cohort Study of Hemodialysis Patients.Protein and energy depletion in chronic hemodialysis patients: clinical applicability of diagnostic tools.Impact of arteriovenous fistula blood flow on serum il-6, cardiovascular events and death: An ambispective cohort analysis of 64 Chinese hemodialysis patients.Bases of cardiovascular and hematological effects.Salivary levels of interleukin-6 and tumor necrosis factor-α in patients undergoing hemodialysis.Serum albumin level and risk for mortality and hospitalization in adolescents on hemodialysis.Endotoxemia is related to systemic inflammation and atherosclerosis in peritoneal dialysis patients.Interdialytic weight gain, systolic blood pressure, serum albumin, and C-reactive protein levels change in chronic dialysis patients prior to deathIs inflammation a new risk factor of depression in haemodialysis patients?Understanding and Managing Atrial Fibrillation in Patients with Kidney Disease.Role of adipose tissue in determining muscle mass in patients with chronic kidney disease.Impact of proteinuria and glomerular filtration rate on risk of thromboembolism in atrial fibrillation: the anticoagulation and risk factors in atrial fibrillation (ATRIA) study.Effects of sevelamer and calcium-based phosphate binders on lipid and inflammatory markers in hemodialysis patients.Inflammation and its impact on anaemia in chronic kidney disease: from haemoglobin variability to hyporesponsiveness.A prospective study: inflammation, infection and comorbidity in patients on long-term dialysis.Statins, inflammation and kidney disease.Noncardiovascular mortality in CKD: an epidemiological perspective.Low baseline serum albumin as a predictor of anemia in chronic hemodialysis patients.B-flow imaging estimation of carotid and femoral atherosclerotic plaques: vessel walls rheological damage or strong predictor of cardiovascular mortality in chronic dialysis patients.A comparison of systemic inflammation-based prognostic scores in patients on regular hemodialysis.Vitamin E-coated cellulose acetate dialysis membrane: long-term effect on inflammation and oxidative stress.White blood cells as a novel mortality predictor in haemodialysis patients.Relationship between Geriatric Nutritional Risk Index and total lymphocyte count and mortality of hemodialysis patients.Parenteral iron compounds sensitize mice to injury-initiated TNF-alpha mRNA production and TNF-alpha release.Novel inflammatory marker in dialysis patients: YKL-40.
P2860
Q30980142-A11DBA64-0C94-4B98-9B1B-B185A045ED48Q33684173-552C70BE-0F50-45FF-A5C1-A2FC08FD93BFQ33863690-16E088F8-052F-485A-AF3D-A6B713403218Q33877500-86C645B4-1906-4D13-83AB-972694A06871Q34385874-471B60F6-DF77-4D4D-B165-5C227AF2CF84Q34541172-91B60F72-E02B-45BA-9B20-04F36340AC19Q35042578-F5E7C4DF-7326-46AE-AAE0-1CADABB90AB1Q35054952-607DE9C3-7748-4E2F-AED3-D704C1692442Q35173478-FE9E1189-28F3-4E92-B5A5-7EB2D8AD3E13Q35267205-FE570851-D743-46BF-A574-09807A3B63F6Q35609145-E3E6502F-F17C-49BD-8C50-C08309763E59Q35609208-F35586C8-C639-485B-B669-910B20744C6EQ35641502-004401F5-69C8-4575-ACE8-07A239ABF439Q35983464-82E8E2FD-C736-4CAC-B941-CF74CAAF95DBQ36034508-AC7C9347-E961-4F4A-83C7-79F61FB0EEECQ36207088-076C2990-255F-427D-9950-48B56B4A8764Q36278331-139013A9-8C1B-4CE1-A3D1-BC57971FAE2DQ36299334-2900C796-F577-4A05-BBA3-722892300719Q36379632-0C6C513B-7039-4103-8901-DDA93CE7311DQ36628703-B0E2F915-0264-4AFE-87ED-B102C478D3A6Q36662039-E9BA2A56-87D5-4302-9D30-39D0CEE1ECCFQ36666840-0D191977-DB54-460B-B695-F0185478A623Q36968792-2FF7DADF-FBBE-48F2-974F-4E7A19AE645CQ37067983-CB4F8FA3-B5DD-4548-8F96-19352957EC9CQ37115706-146ADF76-9538-4F06-8E89-BF321976779EQ37235157-86DD6DD0-6602-4D41-B4F5-125E62399A0EQ37322244-CF8E9A6C-9C76-4AF4-9C48-8F1A2C478D4FQ37449096-52609571-98CE-45A6-BE2B-6BF34F6B789DQ37492328-828E675E-A5F0-498F-92F7-038D3904B06CQ37845374-0F08DBA4-1371-4383-B352-CE983FC06320Q37883015-A8728716-7711-4004-862A-C5B579614B6AQ38184840-8C3A2F89-4C38-444A-8AD9-ED26DB04539BQ38934453-9567B01D-BEF6-4615-A085-6CAD9049DD95Q40625619-A7BB5B8E-B5C3-4D93-B995-1AEE26A13025Q41857248-1BB13085-A4B2-47CE-9499-22C7E8C8128DQ43108544-5A5EE6C9-CE78-4D37-B248-1FFE81B0BA28Q44441930-72CF97E5-DFE4-44BF-A300-ED6C422319A6Q44556463-DA87354B-1F9E-46AE-81AD-E02FCA881D2AQ45115192-D6A84A9A-36BA-477F-A1AC-587C5207080DQ46103273-7FA52785-BD07-4899-9DE9-14F0A044C572
P2860
C-reactive protein as an outcome predictor for maintenance hemodialysis patients.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年学术文章
@wuu
1998年学术文章
@zh-cn
1998年学术文章
@zh-hans
1998年学术文章
@zh-my
1998年学术文章
@zh-sg
1998年學術文章
@yue
1998年學術文章
@zh
1998年學術文章
@zh-hant
name
C-reactive protein as an outcome predictor for maintenance hemodialysis patients.
@en
C-reactive protein as an outcome predictor for maintenance hemodialysis patients.
@nl
type
label
C-reactive protein as an outcome predictor for maintenance hemodialysis patients.
@en
C-reactive protein as an outcome predictor for maintenance hemodialysis patients.
@nl
prefLabel
C-reactive protein as an outcome predictor for maintenance hemodialysis patients.
@en
C-reactive protein as an outcome predictor for maintenance hemodialysis patients.
@nl
P1433
P1476
C-reactive protein as an outcome predictor for maintenance hemodialysis patients.
@en
P2093
P304
P356
10.1046/J.1523-1755.1998.00032.X
P407
P577
1998-08-01T00:00:00Z
P5875
P6179
1028251139